GlaxoSmithKline PLC
LSE:GSK
GlaxoSmithKline PLC
LSE:GSK
Price:
1 775 GBX
-0.48%
Market Closed
Updated:
May 18, 2024
GlaxoSmithKline PLC
Operating Expenses
|
GlaxoSmithKline PLC
Operating Expenses Peer Comparison
Comparables:
AZN
VRNA
INDV
HIK
DPH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Expenses
-£15.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Expenses
-$30.5B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-6%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Operating Expenses
-$67.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Operating Expenses
-$674m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Expenses
-$785m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Operating Expenses
-£404.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-17%
|
See Also
What is GlaxoSmithKline PLC's Operating Expenses?
Operating Expenses
-15.1B
GBP
-15.1B
GBP
Based on the financial report for Mar 31, 2024, GlaxoSmithKline PLC's Operating Expenses amounts to -15.1B GBP.
What is GlaxoSmithKline PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-3%
-3%
Over the last year, the Operating Expenses growth was -17%. The average annual Operating Expenses growth rates for GlaxoSmithKline PLC have been -1% over the past three years , -3% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
